Search Within

Neeta Pandit-Taskar

  1. "2023"
Formats
  1. Meeting Abstract (19)
  2. Journal Article (9)
  3. Review (3)
Groups
  1. Molecular Imaging and Therapy Service (31)
  2. Radiology, Department of (31)
  3. Medical Physics (9)
  4. Sloan Kettering Institute Postdocs (7)
  5. Pediatrics, Department of (6)
  6. Radiochemistry and Imaging Sciences Service (6)

More Groups

People
  1. Jazmin Schwartz (5)
  2. Serge Lyashchenko (5)
  3. Ellen Basu (4)
  4. Shakeel Modak (4)
  5. John Humm (3)
  6. Kim Kramer (3)

More People

Years
  1. 2023 (31)
Publications
  1. Journal of Nuclear Medicine (11)
  2. European Journal of Nuclear Medicine and Molecular Imaging (4)
  3. Journal of Clinical Oncology (4)
  4. Pediatric Blood and Cancer (4)
  5. Oncology Nursing Forum (2)
  6. Blood (1)

More Publications

Publishers
  1. Society of Nuclear Medicine (11)
  2. Springer (5)
  3. American Society of Clinical Oncology (4)
  4. Wiley Periodicals, Inc (4)
  5. Oncology Nursing Society (ONS) (2)
  6. Springer (1)

More Publishers

Results (31)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • High-dose targeted radiation with (131)I-apamistamab prior to HCT demonstrated a dose-response for durable complete remission in patients with R/R AML
    Meeting Abstract

    Litzow, M. R.; Chen, G.; Gyurkocza, B.; Nath, R.; Seropian, S.; Choe, H.; Abboud, C. N.; Koshy, N.; Tomlinson, B. K.; Abhyankar, S.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Individualized dosing for high-dose targeted radiation of hematopoietic cells with Iomab-B (I131-apamistamab) prior to HCT in relapsed/refractory acute myeloid leukemia (R/R AML): Safety and efficacy results from the pivotal phase 3 SIERRA trial
    Meeting Abstract

    Pandit-Taskar, N.; Natwa, M.; Chen, M. K.; Wagner, R.; Yap, W.; Griffeth, L.; Wiseman, G.; Mhlanga, J.; Wahl, R.; Avril, N.; more...
    Journal of Nuclear Medicine (2023)

    Fulltext@MSK | Save
  • 89Zr-DFO-girentuximab PET/CT imaging can accurately detect clear cell renal cell carcinoma primary and secondary lesions in patients with renal masses at conventional imaging, results from ZIRCON phase 3 study
    Meeting Abstract

    Calais, J.; Shuch, B.; Pantuck, A.; Bernhard, J. C.; Morris, M.; Master, V.; Scott, A.; van Praet, C.; Bailly, C.; Aksoy, T.; more...
    Journal of Nuclear Medicine (2023)

    Fulltext@MSK | Save
  • Dose-escalation study of [225Ac]-FPI-1434 (FPI-1434) in patients (pts) with IGF-1R expressing advanced solid tumors: Preliminary pharmacology and dosimetry results
    Meeting Abstract

    Pandit-Taskar, N.; Wong, J.; Subbiah, V.; Chenard-Poirier, M.; Pryma, D.; Berlin, A.; Juergens, R.; Puzanov, I.; Jacene, H.; Schindler, J.; more...
    Journal of Nuclear Medicine (2023)

    Fulltext@MSK | Save
  • Administration and radiation safety of high-dose Iomab-B (I131-apamistamab) demonstrated in multiple clinical settings: Experience from the large multicenter phase 3 SIERRA trial for targeted conditioning of patients with relapsed/refractory AML
    Meeting Abstract

    Serencsits, B.; Prasad, K.; Chen, L.; Senglaub, T.; Zgaljardic, M.; Brodin, P.; McNamara, K.; Desai, A.; Pandit-Taskar, N.
    Journal of Nuclear Medicine (2023)

    Fulltext@MSK | Save
  • Streamlining personalized dosimetry for I131-apamistamab using a Co-57 sheet source to circumvent the need for radionuclide-specific attenuation correction
    Meeting Abstract

    Schwartz, J.; Brodin, P.; Spross, J.; Haeuber, E.; Fisher, D.; Pandit-Taskar, N.
    Journal of Nuclear Medicine (2023)

    Fulltext@MSK | Save
  • TITLE: A pilot study of 89Zr-DFO-REGN3767 anti-LAG-3 antibody positron emission tomography in patients with diffuse large B-cell lymphoma
    Meeting Abstract

    Pandit-Taskar, N.; Shutian, R.; Grkovski, M.; Schwartz, J.; Lyashchenko, S.; Cheung, K.; Uldrick, T.; Ma, D.; Giurleo, J.; Palomba, L.
    Journal of Nuclear Medicine (2023)

    Fulltext@MSK | Save
  • 18F-MFBG PET imaging in patients with neuroblastoma: Lesion targeting and comparison with MIBG
    Meeting Abstract

    Pandit-Taskar, N.; Mauguen, A.; Basu, E.; Price, A.; Behr, G.; Min, R.; Lyashchenko, S.; Schwartz, J.; Modak, S.
    Journal of Nuclear Medicine (2023)

    Fulltext@MSK | Save
  • Machine learning applications to optimize dosimetric imaging of I131-apamistamab for bone marrow conditioning in relapsed/refractory acute myeloid leukemia (R/R AML)
    Meeting Abstract

    Brodin, P.; Schwartz, J.; Wang, W.; Spross, J.; Pandit-Taskar, N.
    Journal of Nuclear Medicine (2023)

    Fulltext@MSK | Save
  • Determination of the treatment coverage of theragnostic (124)I-8H9 antibody to treat diffuse pontine glioma by convective enhance delivery
    Meeting Abstract

    Velo, A. F.; Larsen, A. G.; Humm, J.; Zanzonico, P.; Souweidane, M.; Pandit-Taskar, N.
    European Journal of Nuclear Medicine and Molecular Imaging (2023)

    Fulltext@MSK | Save